share_log

Lake Street Maintains Buy on Evogene, Raises Price Target to $3

Lake Street Maintains Buy on Evogene, Raises Price Target to $3

Lake Street維持對Evogene的買入,將目標價上調至3美元
Benzinga ·  2023/08/18 11:10

Lake Street analyst Ben Klieve maintains Evogene (NASDAQ:EVGN) with a Buy and raises the price target from $2 to $3.

湖街分析師本·克利夫維持Evogene(納斯達克股票代碼:EVGN)的買入,並將目標股價從2美元上調至3美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論